SPY366.69-0.10 -0.03%
DIA300.06+0.88 0.29%
IXIC12,377.18+27.82 0.23%

Harmony Biosciences Q3 EPS $(0.14) Misses $(0.05) Estimate, Sales $45.60M Beat $40.07M Estimate

Harmony Biosciences (NASDAQ:HRMY) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.05) by 180 percent. The company reported quarterly sales of $45.60 million which beat

· 11/12/2020 08:04
Harmony Biosciences (NASDAQ:HRMY) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.05) by 180 percent. The company reported quarterly sales of $45.60 million which beat the analyst consensus estimate of $40.07 million by 13.80 percent.